Logo image of EMX

EMX ROYALTY CORP (EMX) Stock Fundamental Analysis

NYSEARCA:EMX - American Stock Exchange - CA26873J1075 - Common Stock - Currency: USD

1.82  +0.04 (+2.25%)

Fundamental Rating

4

Overall EMX gets a fundamental rating of 4 out of 10. We evaluated EMX against 150 industry peers in the Metals & Mining industry. EMX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. EMX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

EMX had negative earnings in the past year.
EMX had a positive operating cash flow in the past year.
EMX had negative earnings in 4 of the past 5 years.
In multiple years EMX reported negative operating cash flow during the last 5 years.
EMX Yearly Net Income VS EBIT VS OCF VS FCFEMX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.35%, EMX is in line with its industry, outperforming 47.55% of the companies in the same industry.
EMX's Return On Equity of -3.14% is in line compared to the rest of the industry. EMX outperforms 47.55% of its industry peers.
Industry RankSector Rank
ROA -2.35%
ROE -3.14%
ROIC N/A
ROA(3y)-5.04%
ROA(5y)-6.89%
ROE(3y)-7.51%
ROE(5y)-8.54%
ROIC(3y)N/A
ROIC(5y)N/A
EMX Yearly ROA, ROE, ROICEMX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

1.3 Margins

EMX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMX Yearly Profit, Operating, Gross MarginsEMX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1K 2K

More info and screens

6

2. Health

2.1 Basic Checks

EMX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EMX has more shares outstanding
The number of shares outstanding for EMX has been increased compared to 5 years ago.
Compared to 1 year ago, EMX has an improved debt to assets ratio.
EMX Yearly Shares OutstandingEMX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
EMX Yearly Total Debt VS Total AssetsEMX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

EMX has an Altman-Z score of 4.58. This indicates that EMX is financially healthy and has little risk of bankruptcy at the moment.
EMX's Altman-Z score of 4.58 is fine compared to the rest of the industry. EMX outperforms 69.23% of its industry peers.
EMX has a debt to FCF ratio of 9.03. This is a negative value and a sign of low solvency as EMX would need 9.03 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 9.03, EMX is in the better half of the industry, outperforming 62.94% of the companies in the same industry.
EMX has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.30, EMX is not doing good in the industry: 62.94% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 9.03
Altman-Z 4.58
ROIC/WACCN/A
WACC9.93%
EMX Yearly LT Debt VS Equity VS FCFEMX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

EMX has a Current Ratio of 13.15. This indicates that EMX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of EMX (13.15) is better than 91.61% of its industry peers.
A Quick Ratio of 13.15 indicates that EMX has no problem at all paying its short term obligations.
EMX has a Quick ratio of 13.15. This is amongst the best in the industry. EMX outperforms 91.61% of its industry peers.
Industry RankSector Rank
Current Ratio 13.15
Quick Ratio 13.15
EMX Yearly Current Assets VS Current LiabilitesEMX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

5

3. Growth

3.1 Past

EMX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.79%.
Looking at the last year, EMX shows a very negative growth in Revenue. The Revenue has decreased by -28.20% in the last year.
The Revenue has been growing by 65.69% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-36.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-52.33%
Revenue 1Y (TTM)-28.2%
Revenue growth 3Y54.64%
Revenue growth 5Y65.69%
Sales Q2Q%-45.63%

3.2 Future

Based on estimates for the next years, EMX will show a very strong growth in Earnings Per Share. The EPS will grow by 53.56% on average per year.
EMX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.26% yearly.
EPS Next Y-50%
EPS Next 2Y100%
EPS Next 3Y51.83%
EPS Next 5Y53.56%
Revenue Next Year-3.76%
Revenue Next 2Y-0.75%
Revenue Next 3Y2.68%
Revenue Next 5Y11.26%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
EMX Yearly Revenue VS EstimatesEMX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
EMX Yearly EPS VS EstimatesEMX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 -0.1 -0.15

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EMX. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 64.71, EMX can be considered very expensive at the moment.
EMX's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of EMX to the average of the S&P500 Index (92.74), we can say EMX is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 64.71
EMX Price Earnings VS Forward Price EarningsEMX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as EMX.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EMX indicates a somewhat cheap valuation: EMX is cheaper than 60.14% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 78.22
EV/EBITDA 41.64
EMX Per share dataEMX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

A more expensive valuation may be justified as EMX's earnings are expected to grow with 51.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y100%
EPS Next 3Y51.83%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EMX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EMX ROYALTY CORP

NYSEARCA:EMX (2/4/2025, 8:04:00 PM)

1.82

+0.04 (+2.25%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners13.03%
Inst Owner Change0.23%
Ins Owners14.81%
Ins Owner ChangeN/A
Market Cap205.57M
Analysts84
Price Target2.84 (56.04%)
Short Float %0.29%
Short Ratio0.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.34%
PT rev (3m)-33.07%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)40%
EPS NY rev (3m)40%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)10.82%
Revenue NY rev (3m)10.82%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 64.71
P/S 11.23
P/FCF 78.22
P/OCF 78.22
P/B 2.56
P/tB 2.56
EV/EBITDA 41.64
EPS(TTM)-0.02
EYN/A
EPS(NY)0.03
Fwd EY1.55%
FCF(TTM)0.02
FCFY1.28%
OCF(TTM)0.02
OCFY1.28%
SpS0.16
BVpS0.71
TBVpS0.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.35%
ROE -3.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 14.36%
ROA(3y)-5.04%
ROA(5y)-6.89%
ROE(3y)-7.51%
ROE(5y)-8.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 9.03
Debt/EBITDA 4.92
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion 54.48%
Profit Quality N/A
Current Ratio 13.15
Quick Ratio 13.15
Altman-Z 4.58
F-Score4
WACC9.93%
ROIC/WACCN/A
Cap/Depr(3y)10.09%
Cap/Depr(5y)13.67%
Cap/Sales(3y)3.1%
Cap/Sales(5y)3.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-52.33%
EPS Next Y-50%
EPS Next 2Y100%
EPS Next 3Y51.83%
EPS Next 5Y53.56%
Revenue 1Y (TTM)-28.2%
Revenue growth 3Y54.64%
Revenue growth 5Y65.69%
Sales Q2Q%-45.63%
Revenue Next Year-3.76%
Revenue Next 2Y-0.75%
Revenue Next 3Y2.68%
Revenue Next 5Y11.26%
EBIT growth 1Y76.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year770.43%
EBIT Next 3Y127.84%
EBIT Next 5Y105.27%
FCF growth 1Y-76.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-78.65%
OCF growth 3YN/A
OCF growth 5YN/A